Keep up with key industry trends and learn how we’re building patient-centered real-world data to spur medical research.
A basket of patient stories, research updates, and company news.
It’s an exciting time for Alzheimer’s disease research. The FDA approved the first new drug for Alzheimer’s in nearly 20 years in June 2021, and other potential treatments, targeting amyloid plaques in the brain, are making their way through clinical trials.1, 2 It’s a glimmer of hope for Alzheimer’s patients, who number over 6 million in the U.S. alone.
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) are a group of rare conditions that impair the body’s metabolism from breaking down certain fats from food into energy. Although there are an estimated 2,000-3,5000 people living with LC-FAOD in the U.S., researchers have limited data on how LC-FAOD progresses overtime and how it is managed in the real world.
PicnicHealth is working on new research that uses data from medical records to better understand the day-to-day challenges of living with sickle cell. And we're looking for volunteers with sickle cell disease to help.
PicnicHealth gives people with lupus more control navigating their medical care. PicnicHealth does the hard work of tracking down medical records for patients, giving them access to their complete records, organized in one place. And with PicnicHealth, patients can choose to contribute their data to scientific research, which helps life sciences researchers accelerate breakthroughs in care.
Noga Leviner founded PicnicHealth after managing a Crohn's disease diagnosis to give patients more control navigating their own care. PicnicHealth does the hard work of tracking down medical records for patients, giving them access to their complete records, organized in one place. And with PicnicHealth, patients can choose to contribute their data to scientific research, which helps life sciences researchers accelerate breakthroughs in care.
PicnicHealth is proud to partner with WeAreILL to empower women of color living with MS to get better access to their medical records and to contribute to research on their terms.
Learn about the latest research into new treatments for paroxysmal nocturnal hemoglobinuria (PNH), including promising new drugs that have recently been approved by the FDA or are in clinical trials.
Learn about PicnicHealth's mission to support research into new treatments for sickle cell disease, and how we hope to support the sickle cell community.
Learn about the latest research into new treatments for lupus, including several promising new drugs that are in clinical trials.
Learn about research that's being done to find new treatments for multiple sclerosis (MS), including drugs like ocrelizumab, fingolimod, and glatiramer acetate.
Learn what biotech companies are working on a potential coronavirus vaccine and other treatments. Current prospects include Gilead's remdesivir, Moderna Therapeutics mRNA vaccine, Ascletis Pharma ASC-09 and ritonavir, CanSino Ad5-nCoV vaccine, and Abbie's Kaletra.
Learn about what it takes to develop a coronavirus vaccine. Coronavirus causes a disease known as COVID-19. There are a number of biotech companies working to develop a vaccine, including Moderna, Gilead, and more. However, the clinical trial process to ensure safety and effectiveness means that a vaccine likely wouldn't be able for 12 to 18 months at the earliest.